170 related articles for article (PubMed ID: 32152739)
1. Role of Central Hypo-enhancement in the Hepatic Arterial Phase of Dynamic Computed Tomography in Patients with Mass-Forming Intrahepatic Cholangiocarcinoma.
Teraoku H; Morine Y; Uyama N; Ikemoto T; Iwahashi S; Saito Y; Takasu C; Imura S; Harada M; Shimada M
World J Surg; 2020 Jul; 44(7):2350-2358. PubMed ID: 32152739
[TBL] [Abstract][Full Text] [Related]
2. Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings.
Fujita N; Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Moirta K; Shirabe K; Aishima S; Wang H; Oda Y; Honda H
Eur Radiol; 2017 Feb; 27(2):498-506. PubMed ID: 27165138
[TBL] [Abstract][Full Text] [Related]
3. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.
Asayama Y; Yoshimitsu K; Irie H; Tajima T; Nishie A; Hirakawa M; Nakayama T; Kakihara D; Taketomi A; Aishima S; Honda H
Radiology; 2006 Jan; 238(1):150-5. PubMed ID: 16304089
[TBL] [Abstract][Full Text] [Related]
4. Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma.
Yamada S; Morine Y; Imura S; Ikemoto T; Arakawa Y; Saito Y; Yoshikawa M; Miyazaki K; Shimada M
J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):388-395. PubMed ID: 32162483
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics.
Nanashima A; Abo T; Murakami G; Matsumoto A; Tou K; Takeshita H; Kunizaki M; Hidaka S; Sakamoto I; Hayashi H; Fukuda T; Kudo T; Nagayasu T
Abdom Imaging; 2013 Aug; 38(4):785-92. PubMed ID: 23232581
[TBL] [Abstract][Full Text] [Related]
6. Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC).
Jin KP; Sheng RF; Yang C; Zeng MS
Abdom Radiol (NY); 2022 Feb; 47(2):640-650. PubMed ID: 34820689
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
8. Enhancement Patterns of Intrahepatic Cholangiocarcinoma on Contrast-Enhanced Ultrasound: Correlation with Clinicopathologic Findings and Prognosis.
Yuan M; Li R; Zhang Y; Yang L; Zhang X; Tang C; Guo D
Ultrasound Med Biol; 2019 Jan; 45(1):26-34. PubMed ID: 30292461
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic Mass-forming Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis.
Min JH; Kim YK; Choi SY; Kang TW; Lee SJ; Kim JM; Ahn S; Cho H
Radiology; 2019 Mar; 290(3):691-699. PubMed ID: 30620253
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1α for Intrahepatic Cholangiocarcinoma.
Ohta S; Morine Y; Imura S; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Yamada S; Wada Y; Yamashita S; Bando Y; Shimada M
Anticancer Res; 2019 Nov; 39(11):6025-6033. PubMed ID: 31704828
[TBL] [Abstract][Full Text] [Related]
11. Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients.
Baheti AD; Tirumani SH; Shinagare AB; Rosenthal MH; Hornick JL; Ramaiya NH; Wolpin BM
Abdom Imaging; 2014 Dec; 39(6):1193-201. PubMed ID: 24869789
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting the Enhancement Patterns of Intrahepatic Cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their Pathological Correlations in Patients with a Single Lesion.
Yuan MX; Li R; Zhang XH; Tang CL; Guo YL; Guo DY; Luo MK
Ultraschall Med; 2016 Dec; 37(6):609-618. PubMed ID: 25919414
[No Abstract] [Full Text] [Related]
13. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings.
Kim SA; Lee JM; Lee KB; Kim SH; Yoon SH; Han JK; Choi BI
Radiology; 2011 Jul; 260(1):148-57. PubMed ID: 21474703
[TBL] [Abstract][Full Text] [Related]
14. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of contrast-enhanced CT attenuation value in extrahepatic cholangiocarcinoma.
Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Ohtsuka T; Yoshizumi T; Aishima S; Oda Y; Honda H
Eur Radiol; 2017 Jun; 27(6):2563-2569. PubMed ID: 27752833
[TBL] [Abstract][Full Text] [Related]
16. CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma.
Shimada M; Sugimoto K; Iwahashi S; Utsunomiya T; Morine Y; Imura S; Ikemoto T
J Gastroenterol; 2010 Aug; 45(8):896-902. PubMed ID: 20379837
[TBL] [Abstract][Full Text] [Related]
17. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma.
Nanashima A; Sumida Y; Abo T; Oikawa M; Murakami G; Takeshita H; Fukuoka H; Hidaka S; Nagayasu T; Sakamoto I; Sawai T
J Surg Oncol; 2008 Dec; 98(7):535-9. PubMed ID: 18814285
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic mucinous cholangiocarcinoma.
Lin BY; Wu CC; Tsai TH
Kaohsiung J Med Sci; 2020 Sep; 36(9):757-758. PubMed ID: 32492241
[No Abstract] [Full Text] [Related]
19. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
[TBL] [Abstract][Full Text] [Related]
20. Impact of three-dimensional analysis of multidetector row computed tomography cholangioportography in operative planning for hilar cholangiocarcinoma.
Sasaki R; Kondo T; Oda T; Murata S; Wakabayashi G; Ohkohchi N
Am J Surg; 2011 Oct; 202(4):441-8. PubMed ID: 21861978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
